IDIX CC post-mortem: Other than the IDX184 info discussed in #msg-47150426 and #msg-47110029, the only revelation of consequence on the CC was that the formulation of IDX375 (the non-nucleoside “thumb” polymerase inhibitor) has been changed from a choline salt to a free acid in order to increase stability.
If there are any medicinal chemists reading this, feel free to comment :- )
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”